News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Fresenius Kabi Receives U.S. FDA Approval for Biosimilar Stimufend® (pegfilgrastim - fpgk)
Wednesday, September 07, 2022Fresenius Kabi a global health care company that specializes in pharmaceuticals medical technologies and nutrition products for critical and chronic conditions announced today that the United States US Food and Drug Administration FDA has approved it...
U.S. FDA approves first treatment option for generalized pustular psoriasis flares in adults
Tuesday, September 06, 2022The US Food and Drug Administration is the first regulatory authority to approve spesolimab as a treatment option for generalized pustular psoriasis GPP flares in adults Boehringer Ingelheim announced today Spesolimab marketed in the US as SPEVIGO is...
Avacta Announces AVA6000 Receives Orphan Drug Designation From the US Food and Drug Administration
Tuesday, September 06, 2022Avacta Group plc a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative Affimer and preCISION platforms announces that the US Food and Drug Administration FDA has granted Orphan Drug Designation ODD to th...
XNK Therapeutics completes building phase of new GMP facility
Friday, September 02, 2022XNK Therapeutics AB XNK today announced the successful completion of the building phase of the companys new GMP clean room facility All equipment and systems are now installed and qualification of the clean room is complete while validation and quali...
Juniper Biologics Pte. Ltd. signs exclusive license agreement with Helsinn Healthcare SA for LEDAGA® (chlormethine) in Australia, Asia and the Middle East
Friday, September 02, 2022Helsinn Group a fully integrated global biopharma company with a diversified pipeline of innovative oncology assets and strong trackrecord of commercial execution and Juniper Biologics Pte Ltd a scienceled healthcare company focused on researching de...
Mymetics and PCI Biotech Sign a Preclinical Research Collaboration
Thursday, September 01, 2022Mymetics Corporation a pioneer in the research and development of virosome based vaccines and immunotherapies against infectious and life disabling diseases and PCI Biotech OSE PCIB a Norwegian cancer focused biopharmaceutical company have entered in...
Horizon Therapeutics plc Announces Plans to Expand its Development and Manufacturing Facility in Waterford, Ireland
Tuesday, August 30, 2022Horizon Therapeutics plc has announced the submission of a planning application to expand its development and manufacturing facility in Waterford Ireland The expansion aims to include new capabilities for drug substance biologics development and manu...
ANI Pharmaceuticals Announces the Launch of Prochlorperazine Maleate Tablets USP
Tuesday, August 30, 2022ANI Pharmaceuticals Inc today announced the launch of Prochlorperazine Maleate Tablets USP mg and mg ANIs Prochlorperazine Maleate Tablets USP mg and mg are the generic version of the Reference Listed Drug RLD Compazine and were developed in tech...
European Commission Approves FYB201/Ranivisio® (Ranivisio - Ranibizumab), a Biosimilar to Lucentis®
Monday, August 29, 2022Polpharma Biologics Group BV Formycon AG and Bioeq AG have announced that the European Commission EC has granted marketing authorization MA for Ranivisio Ranivisio Ranibizumab a biosimilar to Lucentis ranibizumabinjection in the European Union EU Th...
Biocytogen Expands Partnership with Merck
Friday, August 26, 2022Biocytogen Pharmaceuticals Beijing Co Ltd Biocytogen and Merck have entered into a global licensing agreement for the use of Biocytogens RenMice platform
